Treatment for Seasonal Allergic Rhinitis During Hot Season
Start with intranasal corticosteroid monotherapy as first-line treatment for seasonal allergic rhinitis—this is the most effective single agent and has the strongest evidence base 1.
First-Line Treatment Approach
Intranasal Corticosteroids (INCS) as Monotherapy
Intranasal corticosteroids are superior to all other single agents for controlling seasonal allergic rhinitis symptoms. The 2017 Joint Task Force issued strong recommendations based on high-quality evidence that:
Do NOT routinely add oral antihistamines to intranasal corticosteroids for initial treatment—there is no additional benefit 1. This is a strong recommendation with moderate-quality evidence.
Choose intranasal corticosteroids over leukotriene receptor antagonists (like montelukast)—INCS are significantly more effective 1. This is a strong recommendation with high-quality evidence.
When INCS Alone Is Insufficient
For moderate-to-severe seasonal allergic rhinitis not controlled with INCS monotherapy, add an intranasal antihistamine (like azelastine) to the intranasal corticosteroid 1. This combination provides clinically meaningful additional symptom reduction:
- Symptom reduction with combination therapy: 37.9%
- Symptom reduction with INCS alone: 29.1%
- Symptom reduction with intranasal antihistamine alone: 24.8%
This represents greater than 40% relative improvement over either agent alone 1.
Important caveat: This is a weak recommendation due to:
- Added cost of second medication
- Potential adverse effects (dysgeusia/bad taste 2-13%, somnolence 0.4-1.1%)
- Most patients benefit, but many may not want the combination 1
Practical Treatment Algorithm
Step 1: Begin intranasal corticosteroid (fluticasone, mometasone, or similar) as monotherapy
Step 2: If inadequate control after 1-2 weeks, add intranasal antihistamine (azelastine) to the INCS—either as combination spray or separate devices
Step 3: Continue avoiding oral antihistamine addition unless patient specifically cannot tolerate nasal sprays
Common Pitfalls to Avoid
- Don't start with combination INCS + oral antihistamine—this adds cost and potential side effects without meaningful benefit 1
- Don't use leukotriene receptor antagonists as first-line—they are less effective than INCS 1
- Don't use intramuscular corticosteroids—serious adverse effects outweigh benefits 2
Special Considerations
For predictable seasonal allergies during hot months, start INCS 1-2 weeks before anticipated pollen season for optimal symptom control 3.
If patient refuses nasal sprays, oral antihistamines (second-generation non-sedating agents like cetirizine, desloratadine, or fexofenadine) are acceptable alternatives for mild disease, though less effective than INCS 2, 4.